Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 05  •  04:00PM ET
11.91
Dollar change
-0.03
Percentage change
-0.25
%
IndexRUT P/E- EPS (ttm)-0.78 Insider Own5.80% Shs Outstand41.45M Perf Week-1.73%
Market Cap490.69M Forward P/E- EPS next Y-0.13 Insider Trans0.88% Shs Float38.81M Perf Month7.78%
Enterprise Value455.43M PEG- EPS next Q-0.10 Inst Own90.54% Short Float7.23% Perf Quarter39.62%
Income-32.10M P/S1.63 EPS this Y-120.00% Inst Trans-4.33% Short Ratio6.00 Perf Half Y35.80%
Sales300.72M P/B2.76 EPS next Y61.62% ROA-11.48% Short Interest2.81M Perf YTD30.02%
Book/sh4.32 P/C12.66 EPS next 5Y- ROE-17.10% 52W High13.50 -11.78% Perf Year78.29%
Cash/sh0.94 P/FCF- EPS past 3/5Y-6.93% 28.31% ROIC-17.77% 52W Low6.63 79.64% Perf 3Y-15.47%
Dividend Est.- EV/EBITDA254.43 Sales past 3/5Y-2.57% 2.06% Gross Margin50.69% Volatility3.36% 3.64% Perf 5Y11.73%
Dividend TTM- EV/Sales1.51 EPS Y/Y TTM87.03% Oper. Margin-7.73% ATR (14)0.43 Perf 10Y-5.25%
Dividend Ex-Date- Quick Ratio1.38 Sales Y/Y TTM2.73% Profit Margin-10.67% RSI (14)56.26 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.29 EPS Q/Q15.88% SMA200.80% Beta0.49 Target Price19.33
Payout- Debt/Eq0.02 Sales Q/Q12.18% SMA506.22% Rel Volume0.85 Prev Close11.94
Employees675 LT Debt/Eq0.01 EarningsOct 02 BMO SMA20017.70% Avg Volume467.96K Price11.91
IPOMay 27, 2004 Option/ShortYes / Yes EPS/Sales Surpr.18.30% 4.73% Trades Volume400,078 Change-0.25%
Date Action Analyst Rating Change Price Target Change
Jul-16-25Initiated Lake Street Buy $24
Apr-05-24Upgrade Oppenheimer Perform → Outperform $12
Sep-25-23Initiated H.C. Wainwright Buy $19
Apr-17-23Downgrade Raymond James Strong Buy → Outperform $14 → $13
Oct-15-21Upgrade Canaccord Genuity Hold → Buy $28 → $37
Aug-20-21Initiated Oppenheimer Perform
Nov-25-20Upgrade Raymond James Mkt Perform → Strong Buy $18
Apr-08-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Apr-01-19Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Apr-03-18Upgrade Raymond James Mkt Perform → Outperform
Oct-27-25 04:30PM
Oct-26-25 06:16AM
Oct-13-25 08:30AM
Oct-03-25 12:47PM
08:21AM
03:01PM Loading…
Oct-02-25 03:01PM
12:28PM
07:10AM
06:08AM
06:00AM
Oct-01-25 09:15AM
Sep-22-25 12:27PM
Sep-18-25 08:00AM
Sep-09-25 06:45PM
Aug-28-25 11:30AM
01:30PM Loading…
Aug-21-25 01:30PM
Aug-14-25 04:04AM
Aug-06-25 04:30PM
Jul-28-25 08:30AM
Jul-25-25 11:13AM
Jul-23-25 08:30AM
Jul-18-25 07:02AM
Jul-16-25 12:35PM
03:03AM
Jul-15-25 04:42PM
07:40AM
06:44AM
06:30AM
Jul-14-25 09:18AM
Jul-07-25 08:00AM
10:55AM Loading…
Jun-26-25 10:55AM
08:23AM
Jun-24-25 10:43AM
Jun-23-25 08:00AM
Jun-20-25 11:40AM
11:36AM
Jun-18-25 09:55AM
09:52AM
Jun-17-25 11:39AM
Jun-16-25 11:14AM
Jun-13-25 12:37PM
Jun-11-25 10:28AM
Jun-09-25 11:55AM
11:35AM
Jun-06-25 12:26PM
09:41AM
Jun-05-25 12:07PM
Jun-04-25 12:31PM
12:26PM
12:00PM
Jun-03-25 12:10PM
Jun-02-25 08:38AM
May-30-25 10:14AM
09:40AM
May-29-25 10:08AM
10:06AM
09:31AM
May-28-25 11:50AM
11:47AM
09:22AM
May-26-25 12:42PM
May-23-25 10:46AM
10:36AM
08:41AM
06:52AM
May-22-25 11:39AM
08:26AM
May-21-25 10:48AM
09:44AM
09:10AM
07:21AM
May-20-25 09:22AM
07:53AM
May-19-25 10:12AM
May-16-25 10:22AM
10:12AM
07:59AM
May-15-25 08:40AM
May-14-25 09:40AM
08:49AM
May-13-25 09:41AM
07:07AM
May-12-25 09:10AM
08:40AM
07:24AM
May-09-25 01:29PM
08:49AM
May-08-25 08:13AM
08:09AM
07:54AM
06:52AM
May-07-25 10:05AM
09:35AM
09:20AM
08:34AM
May-06-25 09:04AM
07:10AM
May-05-25 12:59PM
08:46AM
07:24AM
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The firm offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The Med Tech segment consists of technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment focuses on core, venous, ports, and other oncology products. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weiss Lawrence TSVP, Chief Legal OfficerOct 21 '25Buy11.8110,000118,10093,597Oct 22 07:00 AM
Trowbridge Stephen AEVP and CFOOct 13 '25Buy11.168909,932256,629Oct 14 06:11 AM
Clemmer James CPresident and CEOOct 09 '25Buy11.1510,000111,500882,529Oct 09 09:09 PM
Nighan Warren JRSVP Quality and RegulatoryJan 16 '25Sale12.314,06049,97941,817Jan 17 04:05 PM
Nighan Warren JROfficerJan 16 '25Proposed Sale12.314,06049,979Jan 16 04:05 PM